Full Text
Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy

Abstract

Authors

U Restelli S Artale V Pacelli D Croce

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×